Page last updated: 2024-08-22

trilostane and Carcinoma

trilostane has been researched along with Carcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auchus, RJ; Evaul, K; Li, R; Papari-Zareei, M; Sharifi, N1
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N1
Komanicky, P; Melby, JC; Spark, RF1
Barley, V; Blackledge, G; Hutcheon, A; Kaye, S; Keen, C; Rowland, C; Smith, D; Tyrrell, C; Webster, DJ; Williams, CJ1

Other Studies

4 other study(ies) available for trilostane and Carcinoma

ArticleYear
3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.
    Endocrinology, 2010, Volume: 151, Issue:8

    Topics: 17-Hydroxysteroid Dehydrogenases; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Nucleus; Dehydroepiandrosterone; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Male; Models, Biological; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Treatment Failure

2010
Inhibition of steroid sulfatase activity by danazol.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1984, Volume: 123

    Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen

1984
Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:5

    Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Blood Pressure; Carcinoma; Cushing Syndrome; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Hydrocortisone; Kinetics; Male; Middle Aged; Mineralocorticoids; Potassium; Renin

1978
Multicenter study of trilostane: a new hormonal agent in advanced postmenopausal breast cancer.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Breast Neoplasms; Carcinoma; Dexamethasone; Dihydrotestosterone; Female; Humans; Menopause; Multi-Institutional Systems

1987